Cell viability assay

MM Magdalena Mazurkiewicz
EH Ellin-Kristina Hillert
XW Xin Wang
PP Paola Pellegrini
MO Maria Hägg Olofsson
KS Karthik Selvaraju
PD Padraig D’Arcy
SL Stig Linder
request Request a Protocol
ask Ask a question
Favorite

Cell viability was monitored either by the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay or by phase contract microscopy. For the MTT assay, cells were suspended at 5 × 105 cells/ml, and 100 μl aliquots were dispended into 96-well microtiter plates and exposed to drugs as described using DMSO control. At the end of incubations, 10 μl of a stock solution of 5 mg/ml MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide), was added into each well, and the plates were incubated 4 hours at 37°C. Formazan crystals were dissolved with 100 μl of 10% SDS/10 mM HCl solution overnight at 37°C. Absorbance was measured using an ELISA plate reader (Labsystems Multiscan RC) at 590 nm. Short term viability was assessed by phase contrast microscopy.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A